SNS Financial Group, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1557485
MINNEAPOLIS, MN
Position in CRL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$215,223
New position
Shares Held
949
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#401
of 569 holders
Holding Since
Jun 2026
1 quarter on record
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $5,135,597 across 7 Diagnostics & Research names. CRL ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,764 | $1,887,119 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
7,708 | $1,489,339 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,293 | $680,686 | |
| 4 | DHR |
Danaher Corp /De/
|
2,413 | $459,628 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
949 | $215,223 | |
| 6 | WAT |
Waters Corp /De/
|
541 | $202,896 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,511 | $200,706 |
All Filings in CRL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,223 | 949 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||